Therapeutic drug monitoring and tyrosine kinase inhibitors.
about
Effect of various anticoagulants on the bioanalysis of drugs in rat blood: implication for pharmacokinetic studies of anticancer drugsA retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring.Monitoring of erlotinib in pancreatic cancer patients during long-time administration and comparison to a physiologically based pharmacokinetic model.Validated UPLC-MS/MS method for the quantification of dasatinib in plasma: Application to pharmacokinetic interaction studies with nutraceuticals in Wistar rats.
P2860
Therapeutic drug monitoring and tyrosine kinase inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Therapeutic drug monitoring and tyrosine kinase inhibitors.
@en
type
label
Therapeutic drug monitoring and tyrosine kinase inhibitors.
@en
prefLabel
Therapeutic drug monitoring and tyrosine kinase inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Therapeutic drug monitoring and tyrosine kinase inhibitors.
@en
P2093
Alain Eschalier
Damien Richard
Joyce Dohou
Lucie Roche
Mélanie Pouget
Nicolas Authier
Pauline Herviou
P2860
P304
P356
10.3892/OL.2016.4780
P577
2016-06-24T00:00:00Z